Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity
Nineteen new quinazolin-4(3H)-one derivatives 3a-g and 6a-l were designed and synthesised to inhibit EGFR. The antiproliferative activity of the synthesised compounds was tested in vitro against 60 different human cell lines. The most potent compound 6d displayed superior sub-micromolar antiprolifer...
Saved in:
Main Authors: | Amr Sonousi (Author), Rasha A. Hassan (Author), Eman O. Osman (Author), Amr M. Abdou (Author), Soha H. Emam (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
by: Yi Le, et al.
Published: (2020) -
Design, synthesis and antitumor activity of 5-trifluoromethylpyrimidine derivatives as EGFR inhibitors
by: Yaqing Zuo, et al.
Published: (2022) -
Synthesis of some quinazolinones inspired from the natural alkaloid L-norephedrine as EGFR inhibitors and radiosensitizers
by: Mostafa M. Ghorab, et al.
Published: (2021) -
Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents
by: Safoora Poorirani, et al.
Published: (2018) -
Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives
by: Rezvan Rezaee Nasab, et al.
Published: (2018)